BWCS
PFE icon

Beirne Wealth Consulting Services’s Pfizer PFE Stock Holding History

Beirne Wealth Consulting Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,787
Closed -$314K – 177
2019
Q1 		$314K Sell
7,787
-402
-5% -$16.1K 0.25% 129
2018
Q4 		$339K Buy
+8,189
New +$340K 0.29% 109

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Beirne Wealth Consulting Services's PFE Position: Q2 2019 in Review

Beirne Wealth Consulting Services sold out of Pfizer (PFE) in Q2 2019, closing a stake of 7,787 shares — an estimated $314K sold.

Beirne Wealth Consulting Services first reported a position in PFE in Q4 2018 and held it in 2 quarters. The position peaked at $339K in Q4 2018. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Beirne Wealth Consulting Services reported no remaining Pfizer position as of Q2 2019 after selling out during the quarter.
  • Beirne Wealth Consulting Services sold 7,787 Pfizer shares in Q2 2019, an estimated $314K.
  • Beirne Wealth Consulting Services first reported a position in Pfizer in Q4 2018 and held it in 2 quarters.
  • Beirne Wealth Consulting Services's Pfizer position peaked at $339K in Q4 2018.
  • 2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Beirne Wealth Consulting Services's 13F filing for Q2 2019, filed 25 Jul 2019.